Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer
NCT05594082
·
clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Trastuzumab Deruxtecan
Sponsor
Fudan University